1. Home
  2. SOGP vs BRTX Comparison

SOGP vs BRTX Comparison

Compare SOGP & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SOGP
  • BRTX
  • Stock Information
  • Founded
  • SOGP 2010
  • BRTX 1997
  • Country
  • SOGP Singapore
  • BRTX United States
  • Employees
  • SOGP N/A
  • BRTX N/A
  • Industry
  • SOGP
  • BRTX Managed Health Care
  • Sector
  • SOGP
  • BRTX Health Care
  • Exchange
  • SOGP NYSE
  • BRTX Nasdaq
  • Market Cap
  • SOGP 10.0M
  • BRTX 11.3M
  • IPO Year
  • SOGP 2020
  • BRTX N/A
  • Fundamental
  • Price
  • SOGP $2.08
  • BRTX $1.50
  • Analyst Decision
  • SOGP
  • BRTX Strong Buy
  • Analyst Count
  • SOGP 0
  • BRTX 1
  • Target Price
  • SOGP N/A
  • BRTX $18.00
  • AVG Volume (30 Days)
  • SOGP 47.1K
  • BRTX 107.6K
  • Earning Date
  • SOGP 01-01-0001
  • BRTX 11-12-2024
  • Dividend Yield
  • SOGP N/A
  • BRTX N/A
  • EPS Growth
  • SOGP N/A
  • BRTX N/A
  • EPS
  • SOGP N/A
  • BRTX N/A
  • Revenue
  • SOGP $250,401,822.00
  • BRTX $377,000.00
  • Revenue This Year
  • SOGP $37.39
  • BRTX $482.76
  • Revenue Next Year
  • SOGP $3.88
  • BRTX $212.24
  • P/E Ratio
  • SOGP N/A
  • BRTX N/A
  • Revenue Growth
  • SOGP N/A
  • BRTX 189.55
  • 52 Week Low
  • SOGP $1.49
  • BRTX $1.03
  • 52 Week High
  • SOGP $6.70
  • BRTX $3.67
  • Technical
  • Relative Strength Index (RSI)
  • SOGP 54.19
  • BRTX 50.29
  • Support Level
  • SOGP $2.02
  • BRTX $1.39
  • Resistance Level
  • SOGP $2.22
  • BRTX $1.58
  • Average True Range (ATR)
  • SOGP 0.23
  • BRTX 0.09
  • MACD
  • SOGP 0.01
  • BRTX 0.00
  • Stochastic Oscillator
  • SOGP 52.25
  • BRTX 52.36

About SOGP SOUND GROUP INC SPON ADS EA REP 200 ORD SHS(POST SPLIT)

Sound Group Inc is a world-wide audio-centric social and entertainment company. It Leverages broad product portfolio and in-house technologies, Sound Group caters to user interest in audio entertainment and social networking. Sound Group nurtures a globally diverse and inclusive team, drawing on talent from various countries and regions world-wide.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Share on Social Networks: